Dual Immunofluorescence Quantification of Pre- and Postsynaptic Apposition (Synapsin-1 / PSD-95) in Primary Hippocampal Neurons

Neurons cultured on PDL coverslips, fixed at DIV18. Three to four coverslips per condition per dissection; ≥3 independent dissections. Image ≥10 neurons per coverslip, ≥2 secondary/tertiary dendrite segments (≥30 µm each) per neuron. Conditions randomized across coverslips; imaging and analysis performed blinded to condition via coded filenames. A no-primary and single-primary set included on every staining run for spectral/bleed-through control.

BSL-1. Hazards: paraformaldehyde is a fixative, irritant, and probable carcinogen — handle in a fume hood, wear nitrile gloves and goggles, collect PFA waste as hazardous chemical waste. Triton X-100 and methanol-free fixatives are irritants. Sodium azide (preservative in some antibody stocks) is toxic — do not mix with acids and dispose appropriately. Fluorophore-conjugated antibodies handled with standard PPE. Glass coverslips into sharps containers.

No-primary control (secondaries only): confirms secondary specificity and sets background threshold. Single-primary/single-secondary controls: verify absence of channel bleed-through and correct secondary pairing. Positive control: a known synaptogenic condition (e.g., 50 ng/mL BDNF for 48 h) should increase puncta density. Negative/vehicle control: untreated sister coverslips. MAP2 channel serves as the dendrite mask, restricting puncta counts to neuronal dendrites and excluding glial/debris signal.

Healthy DIV18 neurons show discrete synapsin-1 and PSD-95 puncta studding MAP2+ dendrites, with a substantial fraction (>50%) of PSD-95 puncta apposed to synapsin-1. Typical excitatory synapse density is ~0.2-0.5 colocalized puncta/µm dendrite. A synaptogenic treatment may raise this by 20-50%; a synaptotoxic insult may reduce it by 30-50%. Puncta should be ~0.3-0.8 µm in apparent diameter (diffraction-limited).

• 4% paraformaldehyde (PFA) + 4% sucrose in PBS (fixative)
• 0.1-0.2% Triton X-100 in PBS (permeabilization)
• Blocking buffer: 5% normal goat serum (NGS) + 1% BSA in PBS
• Primary: mouse anti-synapsin-1 (1:500), rabbit anti-PSD-95 (1:500), chicken anti-MAP2 (1:1000)
• Secondary: goat anti-mouse Alexa Fluor 488 (1:1000), goat anti-rabbit Alexa Fluor 568 (1:1000), goat anti-chicken Alexa Fluor 647 (1:1000)
• DAPI (300 nM) nuclear stain
• ProLong Gold or Diamond antifade mountant
• PBS (pH 7.4), glass slides, #1.5 coverslips

To fix and immunostain DIV14-21 primary hippocampal neurons for the presynaptic marker synapsin-1 and the postsynaptic density scaffold PSD-95, alongside the dendritic marker MAP2, and to quantify the density of apposed (colocalized) pre/postsynaptic puncta per unit dendrite length as a structural readout of functional excitatory synapses.

1. Aspirate medium; gently wash neurons once with warm PBS.
2. Fix in 4% PFA/4% sucrose for 15 min at room temperature (RT).
3. Wash 3× 5 min with PBS.
4. Permeabilize with 0.1% Triton X-100 in PBS for 10 min at RT.
5. Block in 5% NGS/1% BSA for 1 h at RT.
6. Incubate in primary antibody cocktail (synapsin/PSD-95/MAP2) in blocking buffer overnight at 4 °C.
7. Wash 3× 10 min with PBS.
8. Incubate in secondary antibody cocktail (488/568/647) for 1 h at RT, protected from light.
9. Wash 2× 10 min PBS; counterstain DAPI 5 min; wash once.
10. Mount coverslip cell-side-down on a slide with ProLong antifade; cure overnight at RT in the dark.
11. Image on a confocal microscope (63× oil, 1.4 NA) as 0.3 µm z-stacks; keep laser/gain identical across conditions.

Independent variable: experimental treatment (synaptogenic/synaptotoxic agent vs vehicle). Dependent variables: density of colocalized synapsin/PSD-95 puncta per µm dendrite, individual puncta intensity, and puncta size. Controlled variables: fixation time, antibody lots/dilutions, imaging parameters (laser power, gain, pinhole, pixel size), dendrite order (secondary/tertiary), DIV at fixation, and analysis thresholds.

We hypothesize that bona fide excitatory synapses are defined by tight apposition of synapsin-1 and PSD-95 puncta, and that an experimental manipulation increasing synaptogenesis (e.g., BDNF treatment or activity enhancement) will increase the density of colocalized puncta per micron of MAP2+ dendrite, whereas synaptotoxic insults (e.g., amyloid-β) will reduce it.

Analyze in Fiji/ImageJ using the Synapse Counter or SynQuant plugin, or a custom colocalization macro. Generate a MAP2 dendrite mask; threshold synapsin and PSD-95 channels identically across conditions (e.g., mean + 2 SD or rolling-ball background subtraction radius 10 px). Count overlapping puncta (≥0.1 µm² overlap) within the dendrite mask; normalize to traced dendrite length (Simple Neurite Tracer). Average segments to neuron, neurons to coverslip, coverslips to dissection.

1. High background/diffuse staining: increase blocking time, dilute primaries further, add 0.05% Tween to washes, and extend wash steps. 2. No puncta / weak signal: verify antibody is not expired, confirm permeabilization (PSD-95 is intracellular), and avoid over-fixation (>20 min PFA masks epitopes). 3. Channel bleed-through inflating colocalization: image sequentially, use single-stain controls, and choose spectrally separated fluorophores (488/568/647). 4. Few colocalized puncta despite many single-channel puncta: check z-registration/chromatic aberration with multicolor beads, and ensure z-step ≤0.3 µm. 5. Coverslips dry out / uneven staining: keep in a humidified chamber and use sufficient antibody volume to cover the coverslip.

Use a hierarchical mixed-effects model (segment within neuron within dissection) or average to the dissection level and apply unpaired t-test (two groups) / one-way ANOVA + Tukey (>2 groups), alpha = 0.05. Power: detecting a 25% puncta-density change (SD ~20%) at 80% power requires n ≈ 4 dissections, ≥10 neurons each. Report n at neuron and dissection levels; correct for multiple comparisons.